Best CAR-T Hospitals in Italy

The IRCCS Ospedale San Raffaele is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1971, the SSNcertified hospital is situated in milan, Italy, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 1350.

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.

Casa di Cura La Madonnina uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 1958, this institution is based in milan, Italy, and has 560 beds, with SSN recognition, to assist both local and foreign patients.

The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.

The IRCCS Policlinico San Donato is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1969, the SSNcertified hospital is situated in milan, Italy, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 430.

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.

The IRCCS Ospedale Galeazzi- Sant’Ambrogio is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1963, the SSNcertified hospital is situated in milan, Italy, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 560.

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.